Discovery of 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1750-45-4, and how the biochemistry of the body works.name: 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1750-45-4, name is 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one, introducing its new discovery. name: 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one

NEW LOW SIDE EFFECT PHARMACEUTICAL COMPOSITION CONTAINING ANTITUBERCULOSIS DRUGS

A pharmaceutical composition for treating tuberculotic diseases with no side effect/low side effect is provided by the present invention, which pharmaceutically effective amount of one or more compounds chosen from isoniazid, rifampin, pyrazinamide and ethambutol, and pharmaceutically effective amount of substances which can reduce the side effect of the antituberculosis agents.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1750-45-4, and how the biochemistry of the body works.name: 5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one

Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem